Model DetailsLeukocyte lymphoma
Model Name |
Leukocyte lymphoma | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
lymphoma • all sites: lymphoma |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte | Male |
12.0% (280 of 2343 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
9% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
14% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
16% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
4% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
32% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
12% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
6% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
25.1% (625 of 2486 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
20% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
30% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
28% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
34% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
31% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
62% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
23% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
34% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
19% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
29% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |